In this article, we are going to take a look at where ALX Oncology Holdings Inc. (NASDAQ:ALXO) stands against the other stocks. The stock market pulled back to the red territory on Thursday ...

Fresh from a $105 million third-round financing earlier this month, ALX Oncology has won two FDA fast-track designations for its lead immuno-oncology drug. The Irish-American biotech picked up the ...

(RTTNews) - ALX Oncology Holdings Inc. (ALXO), a biopharmaceutical company focused on oncology treatments, has announced a workforce reduction of approximately 30% as part of its strategy to ...